Literature DB >> 18094518

Risk and protective factors related to mortality from pneumonia among middleaged and elderly community residents: the JACC Study.

Yusuke Inoue1, Akio Koizumi, Yasuhiko Wada, Hiroyasu Iso, Yoshiyuki Watanabe, Chigusa Date, Akio Yamamoto, Shogo Kikuchi, Yutaka Inaba, Hideaki Toyoshima, Akiko Tamakoshi.   

Abstract

BACKGROUND: There have been few systematic investigations into risk and protective factors for pneumonia related mortality for community residents. This study investigated these factors utilizing a large cohort study on Japanese community residents.
METHODS: Subjects, 110,792 individuals (aged 40-79 years) enrolled in 1988-1990, were followed until death, or when they moved away from the surveyed communities, or the end of 2003. Pneumonia death was defined following 480-486 (International Classification of Diseases, 9th Revision) or J12-J18 (10th Revision). Age-adjusted and multivariate hazard ratios were calculated along with 95% confidence intervals using the Cox proportional hazards model.
RESULTS: With 1,112,747 person-years of the study, a total of 1,246 persons died of pneumonia. We found history of blood transfusion (multivariate hazard ratio=2.0 [95% confidence interval: 1.7-2.4]) was a potent novel risk factor. Walking 0.5-1 hour/day (0.8 [0.6-1.0]), 1+ hour/day (0.7 [0.6-0.8]), and/or a history of pregnancy (0.6 [0.4-0.9]) were found to reduce pneumonia mortality. A large body mass index (BMI) (25+kg/m(2)) was a protective factor (0.7 [0.5-0.8]), while low BMI (<18) was confirmed as a risk one (2.1 [1.7-2.6]). Smoking was an important preventable risk factor (1.6 [1.3-1.9], population attributable risk proportion=14%), and its cessation reduced risk (0.7 [0.5-1.0]) to levels comparable to neversmokers (0.7 [0.5-1.0]).
CONCLUSIONS: The risk and protective factors ascertained here for pneumonia mortality among community residents, history of blood transfusion, large BMI, and walking habits, warrant further study. Smoking cessation may effectively reduce pneumonia mortality.

Entities:  

Mesh:

Year:  2007        PMID: 18094518      PMCID: PMC7058467          DOI: 10.2188/jea.17.194

Source DB:  PubMed          Journal:  J Epidemiol        ISSN: 0917-5040            Impact factor:   3.211


Pneumonia poses a serious threat of mortality among the elderly. Aging is accompanied by a gradual physical decline along with alterations in many aspects of immune function. It is important for interventions to consider risk and protective factors in daily life that are associated with aggravating the prognosis of pneumonia. Although many studies on risk factors among hospitalized patients as well as case-control studies have been conducted,[1]-[5] there have been few systematic investigations into community residents' risk factors: smoking,[6]-[8] medical history such as heart disease, stroke, and diabetes mellitus,[7],[8] expiratory volume,[8] and lower body mass index (BMI) [7],[9] are some. These studies were relatively small population studies, and lifestyle influences were largely uncharted. Some lifestyle habits have been reported to be protective against physical decline (including immune response).[10]-[12] The primary aim of the present study, therefore, was to identify factors determining susceptibility or resistance to pneumonia death among community residents. To achieve this, our study has taken advantage of the data available from a large cohort study.

METHODS

Study Cohort

The Japan Collaborative Cohort Study for Evaluation of Cancer Risk (JACC Study), sponsored by the Ministry of Education, Science, Sports and Culture of Japan, was established from 1988 through 1990 in 45 areas in Japan.[13], [14] A total of 110,792 individuals (46,465 men and 64,327 women, aged 40-79 years) participated in municipal health screening examinations and completed a self-administered questionnaire.

Questionnaire

A questionnaire form has the following items: age, measured weight and height, lifestyle (smoking, alcohol consumption, playing sports, walking) and medical history (stroke, hypertension, myocardial infarction, liver disease, renal disease, gallstone, diabetes mellitus, gastroduodenal ulcer, tuberculosis, cancer, blood transfusion, external injury requiring hospitalization, abdominal surgery, and pregnancy). From BMI, which were calculated using weight and height measurements, each participant was categorized as underweight (10alcohol-consumption statuses were divided into three categories (current, past, never). Playing sports was categorized as <1, 1-2, 3-4, or >4 hours a week. Similarly, walking habit was categorized as <0.5, 0.5, 0.5-1, or >1 hour a day. Medical histories were inquired about, using a yes/no question as to whether the participant had a particular medical history. Those with non-marked or missing data in the questionnaire were not used in the analyses.

Outcomes

Participants were followed up until death, or till they moved away from the surveyed community, or to the end of 2003. For mortality surveillance in each community, investigators systematically reviewed the death certificates of any participants, all of which were forwarded to the public health center in the area of residency. Mortality data were sent centrally to the Ministry of Health and Welfare and the underlying causes of death were coded for the National Vital Statistics according to the International Classification of Diseases, 9th Revision (ICD-9), from 1988 through 1994 and the International Classification of Diseases, 10th Revision (ICD-10), from 1995 through 2003, defining pneumonia deaths under 480-486 (ICD-9), and J12-J18 (ICD-10). The date of moving-out from the study area was also annually verified by the investigators in each area by reviewing population-register sheets of the cohort members. The present study was approved by the ethics committees of Nagoya University and the University of Tsukuba.

Data Analysis

The annual mortality rates (AMR) for pneumonia as a national average were calculated from national statistics using the number of pneumonia deaths15 and the population in each age group.[16] Age-adjusted and multivariate hazard ratios (HRs), along with 95% confidence intervals (CIs), were calculated using the Cox proportional hazards model. For serially-categorized variables (BMI, playing sports and walking), associations between pneumonia mortality and a linear trend for these variables were tested. In the multivariate analyses of medical histories and lifestyle factors, baseline age and history of diabetes mellitus were adjusted, and participants with a history of stroke were excluded from the analyses, because these factors are well confirmed risk factors for pneumonia death.[6],[7],[17] Additionally, we calculated the population attributable risk proportion (PARP) to estimate preventable pneumonia. The PARP was calculated using HRs for each significant factor and the proportion of exposure population (Pe) as: PeX(HR - 1) / [PeX(HR - 1) + 1]. HRs were calculated from a multivariate analysis that contained all significant risk factors (baseline age, low-BMI, smoking, little walking, and history of stroke, diabetes mellitus, tuberculosis, cancer and blood transfusion) as variables. In the final model, the relationship between smoking cessation and pneumonia mortality was examined by a multivariate analysis that contained all significant risk factors (baseline age, low-BMI, little walking, and history of stroke, diabetes mellitus, tuberculosis, cancer and blood transfusion), using current-smoker as the reference category.

RESULTS

Demographic Characteristics

Demographic characteristics of the cohort are provided in Table 1. During the observation period of 1,112,747 person-years, 16.0 % (10,367 men and 7,330 women) of the participants died, and 4.3 % (1,773 men and 2,992 women) were lost to follow-up because they moved out of the study areas. A total of 1,246 (791 men and 455 women) died of pneumonia. AMR for pneumonia increased with age, and AMRs in men were more than twice those in women for all age classes (Table 2). Generally, AMRs of the cohort were stably lower than those of the national average, suggesting a possibility that the present study failed to detect some of the pneumonia cases in the cohort. This is especially true for those who moved from their original residence to long-term hospitalization.
Table 1.

Demographic data of the study cohort.

MenWomen
No.4646564327
Observed person-years455263657484
Age (year, mean ± standard deviation)57.6 ± 10.257.9 ± 10.2
Height (cm, mean±standard deviation)162.8 ± 6.6151.0 ± 6.0
Weight (kg, mean ± standard deviation)60.3 ± 8.952.2 ± 7.9
Body mass index (kg/m2, mean ± standard deviation)22.6 ± 3.322.6 ± 3.9
 
Body mass index (kg/m2)*
 10.0-17.91630 (3.7)2628 (4.4)
 18.0-22.923672 (53.9)29958 (50.1)
 23.0-24.910554 (24.0)13848 (23.1)
 25.0-32.98046 (18.3)13400 (22.4)
 
Smoking*
 Current22459 (52.0)3102 (5.6)
 Fomer11681 (27.0)969 (1.7)
 Never9061 (21.0)51521 (92.7)
 
Alcohol consumption*
 Current33278 (74.9)14236 (24.5)
 Fomer2814 (6.3)997 (1.7)
 Never8320 (18.7)42979 (73.8)
 
Medical history*
 Stroke914 (2.3)585 (1.1)
 Hypertension8995 (21.7)13568 (23.6)
 Myocardial infarction1312 (3.2)1688 (3.0)
 Liver disease3078 (8.4)3000 (5.9)
 Renal disease1606 (4.4)2672 (5.3)
 Gallstones1675 (4.4)3075 (5.8)
 Diabetes mellitus2880 (7.1)2408 (4.4)
 Gastroduodenal ulcer9349 (23.0)6398 (11.6)
 Tuberculosis2954 (7.7)2745 (5.2)
 Cancer411 (1.1)1051 (2.1)
 Blood transfusion3953 (10.3)6031 (23.6)
 External injury10098 (29.0)9472 (19.9)
 Abdominal surgery12298 (32.4)12298 (28.3)
 Pregnancy45395 (96.5)
 
Exercise (playing sports)*
 <1 hour/week25606 (68.6)38939 (76.1)
 1-2 hour/week6279 (16.8)7050 (13.8)
 3-4 hour/week2715 (7.3)2785 (5.4)
 More2721 (7.3)2361 (4.6)
 
Exercise (daily walking)*
 <0.5 hour/day4456 (12.6)5257 (10.8)
 0.5 hour/day6621 (18.7)8598 (17.6)
 >0.5-1 hour/day6904 (19.5)10031 (20.6)
 More17455 (49.3)24883 (51.0)

*: No. (%)

Table 2.

Annual mortality rates (AMR) for pneumonia in the study cohort, compared with the national average (Per 10,000 population).

Age(year)CohortNational Average


No. ofParticipants19902001200220031990-20031999-2003


Average (Range)Average (Range)
Men
40-4998290.8---0.1 (0.0-0.8)0.4 (0.3-0.5)
50-59131500.02.50.01.81.1 (0.0-3.1)1.4 (1.2-1.7)
60-69149072.03.50.90.93.5 (0.9-7.8)6.4 (5.0-7.7)
70-79733619.123.118.813.220.5 (11.0-34.0)34.3 (26.2-45.0)
80-89697143.584.594.170.186.0 (17.8-143.5)158.8 (134.4-184.8)
90+-153.5176.1131.9158.8 (131.9-176.1)463.4 (429.7-513.5)
 
Women
40-49128350.0---0.2 (0.0-1.6)0.2 (0.1-0.2)
50-59190440.00.90.00.00.4 (0.0-0.9)0.5 (0.4-0.6)
60-69205872.41.21.21.21.1 (0.0-2.4)2.2 (1.6-2.9)
70-79103295.84.24.68.15.7 (1.8-9.6)13.1 (9.5-16.9)
80-89102819.522.830.041.430.5 (12.8-44.0)74.1 (59.1-85.0)
90+-85.785.345.068.9 (45.0-85.7)255.1 (228.4-290.3)
*: No. (%)

Detection of Potential Risk and Protective Factors by Age-adjusted Analyses

Potential risk and protective factors for pneumonia death from the age-adjusted analyses are shown in Table 3. BMI was associated with pneumonia mortality: Low BMI elevated the risk while the reverse was true for large BMI. Current smoking and ex-drinking habits showed significant risk associations. With regards to medical history; stroke, myocardial infarction, diabetes mellitus, tuberculosis, cancer, and blood transfusion were all found to be associated with mortality risk, while a history of pregnancy in women significantly reduced mortality risk. Exercising (playing sports and walking) showed protective trends, although walking less than 0.5 hour/day habits increased mortality risk.
Table 3.

Age-adjusted analysis of potential factors for pneumonia deaths.

MenWomenTotal



No. (P-Y)*HR (95% CI)pNo. (P-Y)*HR (95% CI)pNo. (P-Y)*p
Body mass index (kg/m2)
 10.0-17.995 (811)1.9 (1.6, 2.4)<.00164 (488)2.3 (1.7, 3.1)<.0012.1 (1.7, 2.5)<.001
 18.0-22.9446 (3976)1.0 (Reference)192 (1904)1.0 (Reference)1.0 (Reference)
 23.0-24.9102 (938)0.7 (0.5, 0.8)<.00165 (599)0.9 (0.7, 1.2)0.3290.7 (0.6, 0.9)<.001
 25.0-32.965 (633)0.6 (0.5, 0.8)<.00153 (552)0.7 (0.5 , 1.0)0.0260.6 (0.5, 0.8)<.001
 
 Trend<.001<.001<.001
 
Smoking
 Current360 (3319)1.5 (1.2, 1.8)<.00129 (273)1.5 (1.0, 2.2)0.0301.5 (1.3, 1.8)<.001
 Fomer235 (2004)1.2 (0.9, 1.4)0.20713 (89)1.1 (0.5, 2.0)0.8941.2 (1.0, 1.4)0.118
 Never134 (1121)1.0 (Reference)349 (3281)1.0 (Reference)1.0 (Reference)
 
Alcohol consumption
 Current442 (4094)0.8 (0.7, 1.0)0.04160 (628)0.8 (0.6, 1.0)0.0840.8 (0.7, 1.0)0.009
 Fomer96 (741)1.4 (1.1, 1.7)0.01420 (177)2.7 (1.7, 4.3)<.0011.6 (1.2, 1.9)<.001
 Never194 (1665)1.0 (Reference)314 (2861)1.0 (Reference)1.0 (Reference)
 
Medical history
 Stroke47 (315)1.3 (1.1, 1.5)0.00520(156)3.1 (2.0, 4.8)<.0012.4 (1.8, 3.0)<.001
 Hypertension234 (2073)2.1 (1.6, 2.9)<.001126 (1137)0.8 (0.7, 1.0)0.0621.1 (0.9, 1.2)0.302
 Myocardial infarction61 (481)1.7 (1.3, 2.2)<.00118 (142)0.8 (0.5, 1.3)0.3661.3 (1.1, 1.7)0.016
 Liver diseases54 (441)1.3 (1.0, 1.7)0.09118 (169)0.9 (0.6, 1.5)0.7361.2 (0.9, 1.5)0.225
 Renal diseases30 (235)1.2 (0.8, 1.7)0.33417 (180)0.9 (0.6, 1.5)0.7131.1 (0.8, 1.5)0.613
 Gallstones35 (275)1.1 (0.7, 1.5)0.79222 (185)0.8 (0.5, 1.2)0.2610.9 (0.7, 1.2)0.579
 Diabetes mellitus74 (635)1.4 (1.1, 1.8)0.00839 (330)1.6 (1.2, 2.3)0.0041.5(1.2, 1.8)<.001
 Gastroduodenal ulcer178 (1568)1.1 (1.0, 1.4)0.15151 (451)1.0 (0.7, 1.3)0.8821.1 (0.9, 1.3)0.243
 Tuberculosis93 (798)1.3 (1.0, 1.6)0.03937 (316)1.5 (1.0, 2.1)0.0281.3 (1.1, 1.6)0.004
 Cancer18 (153)1.8 (1.1, 2.8)0.01917 (121)1.9 (1.2, 3.1)0.0021.8 (1.3, 2.5)0.001
 Blood transfusion125 (1005)1.9 (1.6, 2.3)<.00163 (527)1.8 (1.4, 2.4)<.0011.9 (1.6, 2.2)<.001
 External injury174 (1471)1.1 (0.9, 1.3)0.48666 (602)1.0 (0.8, 1.3)0.9771.1 (0.9, 1.2)0.570
 Abdominal surgery227 (1833)1.2 (1.0, 1.4)0.035109 (1054)0.8 (0.6, 1.0)0.0701.0 (0.9, 1.2)0.606
 Pregnancy343 (3237)0.6 (0.4, 0.9)0.019
 
Exercise (playing sports)
 <1 hour/week368 (3033)1.2 (1.0, 1.5)0.107211 (1946)1.2 (0.9, 1.7)0.2881.2 (1.0, 1.5)0.051
 1-2 hour/week91 (789)1.0 (Reference)35 (281)1.0 (Reference)1.0 (Reference)
 3-4 hour/week50 (448)0.9 (0.6, 1.2)0.43221 (199)0.9 (0.6, 1.4)0.5730.9 (0.7, 1.2)0.619
 More54 (482)0.8 (0.6, 1.1)0.12422 (217)0.9 (0.8, 1.2)0.5510.8 (0.6, 1.1)0.225
 
 Trend<.0010.3530.004
 
Exercise (daily walking)
 <0.5 hour/day85 (601)1.6 (1.2, 2.1)0.00147 (355)1.7 (1.2, 2.5)0.0061.6 (1.3, 2.1)<.001
 0.5 hour/day107 (895)1.0 (Reference)60 (508)1.0 (Reference)1.0 (Reference)
 >0.5-1 hour/day108 (856)0.8 (0.6, 1.1)0.19454 (475)0.8 (0.6, 1.2)0.2530.8 (0.7, 1.0)0.081
 More226 (1981)0.7 (0.6, 0.9)0.008109 (1079)0.7 (0.5, 1.0)0.0240.7 (0.6, 0.9)<.001
 
 Trend<.001<.001<.001

*: Number of participants and observed person-year (parentheses)

HR: hazard ratio

CI: confidence intervals

*: Number of participants and observed person-year (parentheses) HR: hazard ratio CI: confidence intervals

Multivariate Analyses of Possible Risk and Protective Factors

In our multivariate analyses of medical histories and lifestyle factors (playing sports and walking), baseline age, sex, history of diabetes mellitus were adjusted, and participants with a history of stroke were excluded from the analyses. However, even with these adjustments most risk/protective factors identified by Table 3 remained unchanged (Table 4). Associations were also confirmed when early deaths within 5 years of follow-up were excluded (low BMI, multivariate hazard ratio=2.0 [95% confidence interval: 1.6-2.6]; smoking habit, 1.8 [1.4-2.3]; blood transfusion, 1.8 [1.4-2.3]; pregnancy, 0.6 [0.4-1.0]; walking 0.5-1 hour/day, 0.8 [0.6-1.0], and 1+ hour/day, 0.7 [0.6-0.9]). We also confirmed that a daily drinking habit, even a heavy (≥69.0 g/day) one (1.0, [0.8-1.3]), was not significantly associated with pneumonia mortality risk.
Table 4.

Multivariate analysis* of possible factors for pneumonia deaths.

MenWomenTotal



HR (95% CI)pHR (95% CI)pHR (95% CI)p
Body mass index (kg/m2)
 10.0-17.92.0 (1.5, 2.6)<.0012.3 (1.6, 3.1)<.0012.1 (1.7, 2.6)<.001
 18.0-22.91.0 (Reference)1.0 (Reference)1.0 (Reference)
 23.0-24.90.6 (0.5, 0.8)<.0010.8 (0.6, 1.2)0.2900.7 (0.5, 0.8)<.001
 25.0-32.90.6 (0.5, 0.9)0.0030.7 (0.5, 0.9)0.0230.7 (0.5, 0.8)<.001
 
 Trend<.001<.001<.001
 
Smoking
 Current1.6 (1.2, 2.0)<.0011.4 (0.9, 2.2)0.1381.6 (1.3, 1.9)<.001
 Fomer1.2 (0.9, 1.5)0.1671.4 (0.7, 2.7)0.3511.2 (1.0, 1.5)0.109
 Never1.0 (Reference)1.0 (Reference)1.0 (Reference)
 
Alcohol consumption
 Current0.8 (0.7, 1.0)0.0580.9 (0.6, 1.2)0.3700.8 (0.7, 1.0)0.043
 Fomer1.1 (0.8, 1.5)0.6952.8 (1.6, 4.7)<.0011.3 (1.0, 1.7)0.099
 Never1.0 (Reference)1.0 (Reference)1.0 (Reference)
 
Medical History
 Hypertension1.3 (1.1, 1.5)0.0100.8 (0.6, 1.0)0.0541.1 (0.9, 1.2)0.443
 Myocardial infarction1.7 (1.2, 2.4)0.0010.8 (0.5, 1.5)0.5221.3 (0.9, 1.8)0.183
 Tuberculosis1.4 (1.1, 1.8)0.0121.7 (1.1, 2.4)0.0091.5 (1.2, 1.9)<.001
 Cancer1.7 (1.0, 3.0)0.0502.6 (1.5, 4.3)<.0012.1 (1.4, 3.0)<.001
 Blood transfusion2.1 (1.7, 2.7)<.0011.9 (1.4, 2.5)<.0012.0 (1.7, 2.4)<.001
 Pregnancy0.6 (0.4, 0.9)0.017
 
Exercise (playing sports)
 <1 hour/week1.1 (0.8, 1.4)0.5021.4 (0.9, 2.2)0.1081.2 (1.0, 1.5)0.129
 1-2 hour/week1.0 (Reference)1.0 (Reference)1.0 (Reference)
 3-4 hour/week0.9 (0.6, 1.3)0.4871.5 (0.8, 2.7)0.2141.0 (0.7, 1.4)0.951
 More0.7 (0.5, 1.1)0.1221.2 (0.6, 2.2)0.5920.8 (0.6, 1.2)0.283
 
 Trend0.0030.3810.002
 
Exercise (daily walking)
 <0.5 hour/day1.1 (0.8, 1.6)0.5091.5 (1.0, 2.3)0.0821.3 (1.0, 1.7)0.105
 0.5 hour/day1.0 (Reference)1.0 (Reference)1.0 (Reference)
 >0.5-1 hour/day0.8 (0.6, 1.1)0.2730.7 (0.5, 1.1)0.1810.8 (0.6, 1.0)0.096
 More0.7 (0.5, 0.9)0.0050.7 (0.5, 1.0)0.0510.7 (0.6, 0.8)<.001
 Trend<.001<.001<.001

*: Adjusted for age and history of diabetes mellitus. Persons with history of stroke were excluded.

HR: hazard ratio

CI: confidence interval

*: Adjusted for age and history of diabetes mellitus. Persons with history of stroke were excluded. HR: hazard ratio CI: confidence interval

Population Attributable Risk Proportion (PARP)

Among factors of baseline age, smoking, low BMI, little walking, and history of stroke, diabetes mellitus, tuberculosis, cancer, and blood transfusion, smoking accounted for PARP at 14.0%. Other factors were as follows: little walking (9.7%), low BMI (8.6%), history of blood transfusion (7.1%), stroke (3.1%), and tuberculosis (1.7%). These factors in total accounted for 44.2%.

Risk Reduction by Smoking Cessation

In the final model, we examined the association of smoking cessation with pneumonia mortality risk. We used current smokers as the reference category with adjustment of significant variables (baseline age, low BMI, little walking, and history of stroke, diabetes mellitus, tuberculosis, cancer, and blood transfusion). Our results showed that ex-smokers significantly reduced the risk of pneumonia mortality (multivariate hazard ratio = 0.7 [95% confidence interval: 0.5-1.0]) to levels comparable to those in never-smokers (0.7 [0.5-1.0]). Even when early deaths within 5 years of follow-up were excluded, the significant associations between cessation of smoking and reduction of pneumonia mortality risk (0.7 [0.5-1.0]) were confirmed. For ex-smokers, smoking cessation for longer than 5 years before the baseline entry significantly reduced the risk of pneumonia mortality (0.7 [0.5-1.0]) to levels comparable to those in never-smokers. However, we could not accurately test the association between smoking cessation for 0-1 year, or 2-5 years with pneumonia mortality risk, because of the small sample sizes (0-1 years, n=12; 2-5 years, n=33). Therefore, we could not determine an effective minimum cessation period that significantly reduced pneumonia mortality risk.

DISCUSSION

In this large cohort study, we found risk and protective factors that were significantly associated with pneumonia: Blood transfusion history was found to be a newly recognized risk factor while history of pregnancy, large BMI, and daily walking habits were protective factors. We also confirmed that low BMI was a risk factor while cessation of smoking was a protective one which might significantly reduce pneumonia mortality risk. These findings were observed using data from a cohort study of community residents and thus provide useful measures for intervention in respect to fatal pneumonia in the elderly. History of blood transfusion might be related with immunomodulation. Before 1990, blood transfusions in Japan were conducted without white blood cell filters, irradiation, or screening for any bacterial or viral infections.[18] Evidence from a variety of sources suggests that microchimerism by allogeneic blood transfusion increases the incidence of immunomodulation, [19]-[22] and allogeneic donor leucocytes have been considered one of the causes of the immunomodulation effect of transfusion.[23] Such modulation, combined with aging, might result in an increased susceptibility to fatal conditions. It should be considered, however, that the experience of pregnancy, which is known to induce microchimerisms from fetuses,[24] was a protective factor. This conflicting observation, also reported elsewhere,[25] suggested that similar antigen exposure induces either a protective or detrimental effect to the host depending on the milieu of the immune system. Although the Pneumonia Severity Index (PSI) does not account for immunosuppression, pneumonia patients with immunosuppression such as hematological malignancies or bone marrow transplantation were reported to have significantly greater mortality.[26] On the other hand, blood transfusion also could be considered as a surrogate marker for a variety of underlying factors that added to the pneumonia mortality risk. These underlying factors might be cofounders of the association between transfusion and pneumonia mortality risk, being associated with both the need for transfusion and the pneumonia mortality risk. Although we excluded the effect of medical histories surveyed in the questionnaire, there might be unidentified medical histories that engendered a spurious association between transfusion and pneumonia mortality risk. The persistent immunological influences of allogeneic blood transfusions before 1990 and its association with pneumonia mortality warrant further investigation. BMI and some lifestyle factors were also found to be significantly associated with pneumonia mortality risk. Low BMI has been associated with increased risk of infection, possibly due to malnutrition or underlying illness,[7],[9] although obesity has also been suggested to elevate the risk associated with impaired T-and/or B-cell function.[27] A cohort study in the United States reported a U-shaped relationship between BMI and immune dysfunction, showing that not only a low BMI but also a BMI with 27.0+ raise the pneumonia infection risk for men aged 40 to 75 years (compared with 21.0-22.9).[27] Our data on Japanese did not support such a trend, although the range of our data on BMI was limited to between 10 and 33 in the cohort of community residents surveyed here. We also found novel factors related to lifestyle: Exercise habits might be understood as an intermediate variable of being healthy, contrary to previous findings. Exercise habits were reported to reduce a wide range of mortalities,[28] and some reports suggest that physical activity is associated with natural killer cell activity.[29] These factors might also lead to functional independence in daily life. Adults aged 60 years and older who were functionally independent before admission were reported to be more likely to present with less severe pneumonia symptoms than patients who were functionally dependent before admission.[30] Rather more systematic and detailed surveys will be needed to better elucidate the effects of these aspects of lifestyle. The effects of alcohol consumption are also equivocal: one study reports chronic alcoholism increases pneumonia mortality risk,[31] while a significant relationship between drinking habits and pneumonia infection was excluded in another.[27] Our results from multivariate analyses showed ex-drinkers were associated with increased pneumonia mortality risk, while current-drinkers and even heavy-drinkers were not significantly associated with mortality risk. This might mean that a behavioral problem of a predisposition to alcohol abuse or other unspecified conditions that required quitting a drinking habit might be an important factor, as suggested in another study.[32] Although we could not find an effective minimum smoking cessation period, we did demonstrate that smoking cessation might be effective in reducing, to a certain degree, the risk of pneumonia mortality. While the preventable portion of pneumonia infection by smoking cessation in the general population aged 18 to 64 years is reported to be 51%,[33] our results for mortality showed that smoking cessation was still a significant measure (14%) against fatal conditions. We confirmed that various medical histories are associated with pneumonia mortality risk,[6],[7],[17] Additionally, our results newly revealed that some medical histories were associated with pneumonia mortality risk. Further etiological research will be needed on these newly identified medical histories. The present study has several limitations. First, we did not detect any incident diseases or smoking status following baseline entry. Therefore any smoking cessation during follow-up was not included. Second, we could not take into account more detailed classifications of pneumonia death, potential confoundings from vaccinations, or other unmeasured items that might affect smoking cessation or pulmonary disease histories.[7],[8] For example, compared with current smokers, ex-smokers may be more health conscious, while some of them quit smoking because of illness; the net effect of these factors is uncertain.[34] Furthermore, we could not confirm the reason for the blood transfusion, their frequency, the number of transfused blood units, or if there were unknown infectious agents. These factors might contain some unrecognized confounding effects related to the associations we found. Finally, there is a possibility that some of the pneumonia cases had been lost, specifically those who left their original communities to undergo long-term hospitalization. In conclusion, the present study demonstrated possible risk and protective factors for pneumonia death based on a prospective mega-cohort of community residents. Our results showed that a history of blood transfusion significantly increased pneumonia mortality risk, and that low BMI and smoking habit were confirmed as risk factors. Contrarily, smoking cessation, walking habit, pregnancy in women, and a large BMI were found to reduce pneumonia mortality risk. Confirmation of the associations between the risk/protective factors suggested here and pneumonia mortality in other populations, and investigations related to their operative mechanisms await further study.
  32 in total

1.  Risk factors for community-acquired pneumonia in adults: a population-based case-control study.

Authors:  J Almirall; I Bolíbar; X Balanzó; C A González
Journal:  Eur Respir J       Date:  1999-02       Impact factor: 16.671

2.  Choice of comparison group in assessing the health effects of moderate alcohol consumption.

Authors:  Y Tsubono; S Yamada; Y Nishino; I Tsuji; S Hisamichi
Journal:  JAMA       Date:  2001-09-12       Impact factor: 56.272

3.  Prospective study of pneumonia hospitalizations and mortality of U.S. older people: the role of chronic conditions, health behaviors, and nutritional status.

Authors:  A Z LaCroix; S Lipson; T P Miles; L White
Journal:  Public Health Rep       Date:  1989 Jul-Aug       Impact factor: 2.792

4.  Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial.

Authors:  L M van de Watering; J Hermans; J G Houbiers; P J van den Broek; H Bouter; F Boer; M S Harvey; H A Huysmans; A Brand
Journal:  Circulation       Date:  1998-02-17       Impact factor: 29.690

5.  Japan collaborative cohort study for evaluation of cancer risk sponsored by monbusho (JACC study).

Authors:  Y Ohno; A Tamakoshi
Journal:  J Epidemiol       Date:  2001-07       Impact factor: 3.211

6.  A prospective study of age and lifestyle factors in relation to community-acquired pneumonia in US men and women.

Authors:  I Baik; G C Curhan; E B Rimm; A Bendich; W C Willett; W W Fawzi
Journal:  Arch Intern Med       Date:  2000-11-13

7.  Risk of community-acquired pneumococcal bacteremia in patients with diabetes: a population-based case-control study.

Authors:  Reimar Wernich Thomsen; Heidi Holmager Hundborg; Hans-Henrik Lervang; Søren Paaske Johnsen; Henrik Carl Schønheyder; Henrik Toft Sørensen
Journal:  Diabetes Care       Date:  2004-05       Impact factor: 19.112

8.  Physical activity and mortality in frail, community-living elderly patients.

Authors:  Francesco Landi; Matteo Cesari; Graziano Onder; Fabrizia Lattanzio; Ester Manes Gravina; Roberto Bernabei
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2004-08       Impact factor: 6.053

9.  High alcohol intake as a risk and prognostic factor for community-acquired pneumonia.

Authors:  J Fernández-Solá; A Junqué; R Estruch; R Monforte; A Torres; A Urbano-Márquez
Journal:  Arch Intern Med       Date:  1995 Aug 7-21

10.  Profile of the JACC study.

Authors:  Akiko Tamakoshi; Takesumi Yoshimura; Yutaka Inaba; Yoshinori Ito; Yoshiyuki Watanabe; Katsuhiro Fukuda; Hiroyasu Iso
Journal:  J Epidemiol       Date:  2005-03       Impact factor: 3.211

View more
  30 in total

1.  Obesity paradox, obesity orthodox, and the metabolic syndrome: An approach to unity.

Authors:  Jesse Roth; Navneet Sahota; Priya Patel; Syed Faizan Mehdi; Mohammad Masum Wiese; Hafiz B Mahboob; Michelle Bravo; Daniel J Eden; Muhammad A Bashir; Amrat Kumar; Farah Alsaati; Irwin J Kurland; Wunnie Brima; Ann Danoff; Alessandra L Szulc; Valentin A Pavlov; Kevin J Tracey; Huan Yang
Journal:  Mol Med       Date:  2016-11-16       Impact factor: 6.354

2.  Relationship Between Body Mass Index and Outcomes Among Hospitalized Patients With Community-Acquired Pneumonia.

Authors:  Anna M Bramley; Carrie Reed; Lyn Finelli; Wesley H Self; Krow Ampofo; Sandra R Arnold; Derek J Williams; Carlos G Grijalva; Evan J Anderson; Chris Stockmann; Christopher Trabue; Sherene Fakhran; Robert Balk; Jonathan A McCullers; Andrew T Pavia; Kathryn M Edwards; Richard G Wunderink; Seema Jain
Journal:  J Infect Dis       Date:  2017-06-15       Impact factor: 5.226

3.  Impact of obesity on outcomes for patients hospitalised with pneumonia.

Authors:  Phoebe King; Eric M Mortensen; Mary Bollinger; Marcos I Restrepo; Laurel A Copeland; Mary Jo V Pugh; Brandy Nakashima; Antonio Anzueto; Polly Hitchcock Noël
Journal:  Eur Respir J       Date:  2012-08-30       Impact factor: 16.671

Review 4.  Risk factors and severity scores in hospitalized patients with community-acquired pneumonia: prediction of severity and mortality.

Authors:  T Welte
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-01       Impact factor: 3.267

Review 5.  Obesity and respiratory infections: does excess adiposity weigh down host defense?

Authors:  Peter Mancuso
Journal:  Pulm Pharmacol Ther       Date:  2012-05-24       Impact factor: 3.410

6.  How obesity impacts outcomes of infectious diseases.

Authors:  A Atamna; A Elis; E Gilady; L Gitter-Azulay; J Bishara
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-11-18       Impact factor: 3.267

Review 7.  Recurrent pneumonia: a review with focus on clinical epidemiology and modifiable risk factors in elderly patients.

Authors:  T T Dang; S R Majumdar; T J Marrie; D T Eurich
Journal:  Drugs Aging       Date:  2015-01       Impact factor: 3.923

8.  Obesity and outcomes in patients hospitalized with pneumonia.

Authors:  S Kahlon; D T Eurich; R S Padwal; A Malhotra; J K Minhas-Sandhu; T J Marrie; S R Majumdar
Journal:  Clin Microbiol Infect       Date:  2012-09-11       Impact factor: 8.067

9.  Rates and risk factors for recurrent pneumonia in patients hospitalized with community-acquired pneumonia: population-based prospective cohort study with 5 years of follow-up.

Authors:  T T Dang; D T Eurich; D L Weir; T J Marrie; S R Majumdar
Journal:  Clin Infect Dis       Date:  2014-04-11       Impact factor: 9.079

10.  Lifestyle risk factors and infectious disease mortality, including COVID-19, among middle aged and older adults: Evidence from a community-based cohort study in the United Kingdom.

Authors:  Matthew N Ahmadi; Bo-Huei Huang; Elif Inan-Eroglu; Mark Hamer; Emmanuel Stamatakis
Journal:  Brain Behav Immun       Date:  2021-04-30       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.